I am a healthcare professional in the UK
I am a patient or member of the public
British Transplantation Society Treatment Algorithm Infographic
British Transplantation Society Treatment Algorithm Infographic
This resource outlines a treatment algorithm for managing cytomegalovirus (CMV) infection in adult patients following solid organ transplantation (SOT), where resistance to standard therapy is suspected. Based on British Transplantation Society (BTS) guidelines, it highlights key steps such as monitoring CMV viral load, assessing treatment adherence and absorption, and confirming resistance through genetic testing. The infographic is designed to support clinical decision-making in line with national guidance.
You might be interested in
1 minute
download
This concise guide to LIVTENCITY® (maribavir) is designed for clarity and ease of use. It summarises key insights from the Phase 3 SOLSTICE trial, including efficacy outcomes, safety data, and practical dosing guidance.
article
6 minutes
A summary of the safety profile of LIVTENCITY, including adverse event data and tolerability findings from clinical studies.
article
5 minutes
Key efficacy outcomes from clinical trials evaluating LIVTENCITY in patients with post-transplant CMV, including virologic response and treatment comparisons.
article
3 minutes
CMV is one of the most common infections experienced by transplant recipients
article
4 minutes
An overview of the pivotal Phase 3 SOLSTICE trial, outlining the study design, patient population, and methodology that underpin the clinical evidence for LIVTENCITY.
